Abstract
This article is the first in a series of articles that will focus on understanding the implementation essentials necessary to deliver operational excellence through a International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Q10-based pharmaceutical quality system (PQS). The authors examine why, despite the fact that the ICH Q10 guideline has been with us since 2008, the transformation of the traditional Quality Management Systems QMS in use within the pharmaceutical industry is a work in progress for only a few forward-thinking organisations. Unfortunately, this transformation remains a mere aspiration for the majority of organisations. We explore the apparent lack of progress by the pharmaceutical sector in adopting six sigma and related quality management techniques to ensure the availability of high-quality medicines worldwide. The authors propose that the desired progress can be delivered through two key shifts in our current practices; by embodying the principles of operational excellence in every aspect of our business and by learning how to unlock the scientific and tacit knowledge within our organisations.
| Original language | English |
|---|---|
| Pages (from-to) | 581-600 |
| Number of pages | 20 |
| Journal | PDA journal of pharmaceutical science and technology |
| Volume | 67 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - Nov 2013 |
Keywords
- Continual improvement
- ICH Q10 Pharmaceutical Quality System (PQS)
- ICH Q8 (R2) product development
- ICH Q9 Quality Risk Management (QRM)
- Implementation
- Innovation
- Knowledge creation and management
- Leadership
- Lean manufacturing
- Operational excellence
- Regional regulatory enforcement
- Senior and corporate management responsibilities
- Six sigma
- The International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH)